Carysil 향후 성장
Future 기준 점검 3/6
Carysil (는) 각각 연간 17.4% 및 15.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 17.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 17.4% 로 예상됩니다.
핵심 정보
17.4%
이익 성장률
17.35%
EPS 성장률
| Building 이익 성장 | 20.7% |
| 매출 성장률 | 15.5% |
| 향후 자기자본이익률 | 17.43% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 22 May 2026 |
최근 향후 성장 업데이트
Recent updates
내러티브 업데이트 • Jun 18
524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance
Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.내러티브 업데이트 • Jun 02
524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.내러티브 업데이트 • May 17
524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).내러티브 업데이트 • Apr 28
524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside
Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.내러티브 업데이트 • Apr 12
524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside
Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).내러티브 업데이트 • Mar 28
524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.내러티브 업데이트 • Mar 11
524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).내러티브 업데이트 • Feb 25
524091: Upcoming Results And Steady Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.내러티브 업데이트 • Feb 11
524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside
Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).내러티브 업데이트 • Jan 27
524091: Steady Outlook And Upcoming Results Date Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.내러티브 업데이트 • Jan 10
524091: Steady Assumptions And Upcoming Results Will Support Future Upside
Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.내러티브 업데이트 • Dec 15
524091: Capacity Expansion Will Drive Future Earnings Momentum
Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).내러티브 업데이트 • Dec 01
524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum
Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).내러티브 업데이트 • Nov 16
524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook
Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).내러티브 업데이트 • Aug 18
Global Kitchen Upgrades And Market Expansion Will Transform Industry
Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
새로운 내러티브 • Feb 18
Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions
Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.이익 및 매출 성장 예측
| 날짜 | 매출 | 이익 | 자유현금흐름 | 영업현금흐름 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2028 | 12,661 | 1,390 | 491 | 1,244 | 3 |
| 3/31/2027 | 11,100 | 1,150 | 476 | 1,148 | 1 |
| 3/31/2026 | 9,240 | 982 | -28 | 1,087 | N/A |
| 12/31/2025 | 8,944 | 897 | N/A | N/A | N/A |
| 9/30/2025 | 8,750 | 811 | 203 | 817 | N/A |
| 6/30/2025 | 8,414 | 707 | N/A | N/A | N/A |
| 3/31/2025 | 8,156 | 637 | 129 | 602 | N/A |
| 12/31/2024 | 8,019 | 608 | N/A | N/A | N/A |
| 9/30/2024 | 7,868 | 635 | -1,289 | -452 | N/A |
| 6/30/2024 | 7,433 | 622 | N/A | N/A | N/A |
| 3/31/2024 | 6,838 | 579 | -397 | 534 | N/A |
| 12/31/2023 | 6,388 | 548 | N/A | N/A | N/A |
| 9/30/2023 | 5,886 | 515 | 207 | 812 | N/A |
| 6/30/2023 | 5,642 | 453 | N/A | N/A | N/A |
| 3/31/2023 | 5,939 | 524 | 133 | 712 | N/A |
| 12/31/2022 | 5,872 | 564 | N/A | N/A | N/A |
| 9/30/2022 | 5,775 | 616 | 28 | 737 | N/A |
| 6/30/2022 | 5,577 | 700 | N/A | N/A | N/A |
| 3/31/2022 | 4,839 | 648 | -256 | 516 | N/A |
| 12/31/2021 | 4,456 | 614 | N/A | N/A | N/A |
| 9/30/2021 | 4,051 | 563 | 44 | 659 | N/A |
| 6/30/2021 | 3,613 | 480 | N/A | N/A | N/A |
| 3/31/2021 | 3,097 | 391 | 89 | 454 | N/A |
| 12/31/2020 | 2,734 | 300 | N/A | N/A | N/A |
| 9/30/2020 | 2,591 | 247 | 243 | 402 | N/A |
| 6/30/2020 | 2,542 | 209 | N/A | N/A | N/A |
| 3/31/2020 | 2,762 | 221 | 102 | 301 | N/A |
| 12/31/2019 | 2,772 | 223 | N/A | N/A | N/A |
| 9/30/2019 | 2,662 | 186 | N/A | 286 | N/A |
| 6/30/2019 | 2,594 | 187 | N/A | N/A | N/A |
| 3/31/2019 | 2,516 | 172 | N/A | 237 | N/A |
| 12/31/2018 | 2,370 | 155 | N/A | N/A | N/A |
| 9/30/2018 | 2,226 | 143 | N/A | N/A | N/A |
| 6/30/2018 | 2,128 | 126 | N/A | N/A | N/A |
| 3/31/2018 | 1,965 | 120 | N/A | 156 | N/A |
| 12/31/2017 | 1,877 | 117 | N/A | N/A | N/A |
| 9/30/2017 | 1,806 | 106 | N/A | N/A | N/A |
| 6/30/2017 | 1,792 | 99 | N/A | N/A | N/A |
| 3/31/2017 | 1,810 | 73 | N/A | 57 | N/A |
| 12/31/2016 | 1,894 | 90 | N/A | N/A | N/A |
| 9/30/2016 | 1,907 | 101 | N/A | N/A | N/A |
| 6/30/2016 | 1,796 | 94 | N/A | N/A | N/A |
| 3/31/2016 | 1,738 | 109 | N/A | 106 | N/A |
애널리스트 향후 성장 전망
수입 대 저축률: 524091 의 연간 예상 수익 증가율(17.4%)이 saving rate(6.9%)보다 높습니다.
수익 vs 시장: 524091 의 연간 수익(17.4%)이 Indian 시장(16.3%)보다 빠르게 성장할 것으로 예상됩니다.
고성장 수익: 524091 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: 524091 의 수익(연간 15.5%)이 Indian 시장(연간 10.9%)보다 빠르게 성장할 것으로 예상됩니다.
고성장 매출: 524091 의 수익(연간 15.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.
주당순이익 성장 예측
향후 자기자본이익률
미래 ROE: 524091의 자본 수익률은 3년 후 17.4%로 낮을 것으로 예상됩니다.
성장 기업 찾아보기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/07/31 16:43 |
| 종가 | 2026/07/31 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2026/03/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Carysil Limited는 7명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Rishab Bothra | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Vyom Chheda | BP Wealth Management Private Limited |